Buradasınız

Anasayfa » Content

CANDİDA KEFYR İLE OLUŞAN PNÖMONİ

CANDIDA KEFYR PNEUMONIA

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2005

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Commensal Candida spp can cause infection in immunocompromised patients. Though most of the infections are caused by albicans subtype of Candida, non-albicans Candida as a cause of infection is on the rise. Non-albicans Candida infections can range from urinary infections to sepsis in intensive care units. Candida kefyr is one of the rare forms of non-albicans Candida. In this case report, a case of Candida kefyr pneumonia in a patient with myelodsysplastic syndrome with febrile neutropenia is presented. The patient clinically responded to ampirically started caspofungin therapy.
Bookmark/Search this post with
Abstract (Original Language): 
Normal insan floras›nda bulunan Candida türleri, immunsüpresyon geliflmesi halinde infeksiyona neden olabilir. Candida infeksiyonlar› s›kl›kla albikans sufllar›yla gözlenmekle beraber, son zamanlarda albikans d›fl› sufllar ile olan infeksiyonlar›n s›kl›¤› artm›flt›r. Albikans d›fl› sufllar ile oluflan infeksiyonlar, özellikle yo¤un bak›m ünitelerinde yatan hastalarda, üriner sistem infeksiyonundan sepsise kadar de¤iflen klinik bulgular ile karfl›m›za ç›kabilir. Bunlardan biri olan Candida Kefyr nadiren saptanabilen fungal bir patojendir. Bu olgu sunumunda, myelodisplastik sendrom zemininde geliflen ve etyolojisinde Candida Kefyr’in saptand›¤› pnömoni olgusu sunuldu. Ampirik olarak bafllanan kaspofungin tedavisine klinik yan›t al›nd›.
FULL TEXT (PDF): 
PDF icon arastirmax-candida-kefyr-ile-olusan-pnomoni.pdf
  • 1
26-28
  • Turkish

REFERENCES

References: 

1. Borg von Zepelin M, Eiffert H, Kann M et al. Changes in the
spectrum of fungal isolates: results from clinical specimens gathered
in 1987/1988 compared with those in 1991/1992 in the
University Hospital Gottigen, Germany. Mycoses 1993; 36:247-
253.
2. Corpus K, Hegeman-Dingle R, Bajjoka I. Candida kefyr, an uncommon
but emerging fungal pathogen: report of two cases.
Pharmacotherapy 2004; 24:1084-1088.
3. Di Bonaventura G, Spedicato I, Picciani C et al. In vitro pharmacodynamic
characteristics of amphotericin B, caspofungin, fluconazole
and voriconazole against bloodstream isolates of infrequent
Candida species from patients with hematologic malignancies.
Antimicrob Agents Chemother 2004; 48:4453-4456.
4. Dorko E, Kmetova M, Pilipcinec E et al. Rare non-albicans Candida
species detected in different clinical diagnoses. Folia Microbiol
(Praha) 2000; 45:364-368.
5. Farina C, Vailati F, Manisco A, Goglio A. Fungaemia survey: a
10-year experience in Bergamo, Italy. Mycoses 1999; 42:543-
548.
6. Hodgin UG Jr. Cystitis due to Candida pseudotropicalis. Rocky
Mt Med J 1969; 66:30-32.
7. Larone DH 1995. Medically Important Fungi- AGuide to Identification,
3 rd ed. ASM Press, Washington, D.C.
8. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia:
pathogenicity and antifungal resistance. J Hosp Infect.
2002; 50:243-260.
9. Nguyen MH, Peacock JE Jr, Morris AJ. The changing face of
candidemia: emergence of non-Candida albicans species and antifungal
resistance. Am J Med 1996; 100:617-623.

Thank you for copying data from http://www.arastirmax.com